The objective of the study was to investigate the inhibitory effect of Drynaria fortunei extract on human myeloma SP2 cells. Three different total extracts of Drynaria fortunei were obtained by reflux extraction method using different organic solvents including ethanol, methanol and petroleum ether. Their anticancer activities on SP20 cells were tested, and the maximum inhibition rate was obtained. The inhibitory effects on tumour cells at 12 h, 24 h, 36 h and 48 h were tested, and the inhibition curves at different time periods were plotted. The results showed that the methanol and ethanol extracts have similar inhibition rates at 24 h, which are around 55%. On the other hand, the maximum inhibition rate of petroleum ether extract is only 36% within 24h. Moreover, within the time periods of 36 h and 48 h, its inhibition rates are all below 10%.
Introduction
Flavonoid compounds are the main active constituents of Drynaria fortunei medicinal herb, which biological activities include the promotion of fracture healing, prevention and treatment of osteoporosis, antioxidation, blood lipid regulation, anti-inflammation, and analgesia (Liu et al., 2001; Suna et al., 2002; Liu et al.,2012) . However, the anticancer activities of Drynaria fortunei and related extracts have not been widely studied. Therefore, this paper chooses myeloma SP20 cells to perform anticancer activity analysis. Because of its good biological activities, its total flavonoids can significantly improve the bone density in ovariectomised rats, inhibit TNFA, IL-6 levels in serum, and promote IL-4 secretion (Xie et al., 2004). It is of great referential significance for the treatment of osteoporosis. And a study has demonstrated the presence of relatively highly active substances in the aqueous and ethanol extracts of Drynaria fortunei which contribute to bone cell proliferation, differentiation and calcification (Tang et al., 2004) . In China, the survival of patients with bone metastases has been prolonged using the kidney and spleen nourishing Chinese medicines, and Drynaria fortunei is one of those Chinese medicines. Therefore, it is reasonable to study the inhibitory activity of Drynaria fortunei on myeloma SP20 cells (Chen, 2004 ).
Materials and methods

Materials
Chinese medicine Drynaria fortunei was purchased from Xiamen Traditional Chinese Medicine Co., Ltd., and was 
Discussion
This experiment studies the inhibitory effects of methanol extract, ethanol extract and petroleum ether extract of ., 2012) . In an experiment exploring the effects of Drynaria fortunei on serum interleukin-2 (IL-2), peripheral blood T cell subsets, brain cell apoptosis and Casepase-3 expression in severe craniocerebral injury rats, the results show that after taking Drynaria fortunei, serum IL-2 level decline is significantly improved and apoptosis is significantly reduced in severe craniocerebral injury rats at 24 h after injury, without affecting Casepase-3 expression, indicating that Drynaria fortunei has an inhibitory effect on early apoptosis in severe craniocerebral injury in rats. This effect may be related to its ability to fight against the decline in serum IL-2 content (Pan et al., 2012).
